These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27288429)

  • 21. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
    Chapman AB; Guay-Woodford LM; Grantham JJ; Torres VE; Bae KT; Baumgarten DA; Kenney PJ; King BF; Glockner JF; Wetzel LH; Brummer ME; O'Neill WC; Robbin ML; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
    Kidney Int; 2003 Sep; 64(3):1035-45. PubMed ID: 12911554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis of hypertension in autosomal dominant polycystic kidney disease.
    Chapman AB; Schrier RW
    Semin Nephrol; 1991 Nov; 11(6):653-60. PubMed ID: 1767138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ambulatory blood pressure correlates with renal volume and number of renal cysts in children with autosomal dominant polycystic kidney disease.
    Seeman T; Dusek J; Vondrichová H; Kyncl M; John U; Misselwitz J; Janda J
    Blood Press Monit; 2003 Jun; 8(3):107-10. PubMed ID: 12900587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertension in children with autosomal dominant polycystic kidney disease (ADPKD).
    Cadnapaphornchai MA
    Curr Hypertens Rev; 2013 Feb; 9(1):21-6. PubMed ID: 23971640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular hypertrophy in hypertensive patients with autosomal dominant polycystic kidney disease: influence of blood pressure and humoral and neurohormonal factors.
    Martinez-Vea A; Valero FA; Bardaji A; Gutierrez C; Broch M; Garcia C; Richart C; Oliver JA
    Am J Nephrol; 2000; 20(3):193-200. PubMed ID: 10878400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood pressure and renal function in autosomal dominant polycystic kidney disease.
    Seeman T; Sikut M; Konrad M; Vondrichová H; Janda J; Schärer K
    Pediatr Nephrol; 1997 Oct; 11(5):592-6. PubMed ID: 9323285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracranial aneurysms in patients with autosomal dominant polycystic kidney disease: prevalence, risk of rupture, and management. A systematic review.
    Cagnazzo F; Gambacciani C; Morganti R; Perrini P
    Acta Neurochir (Wien); 2017 May; 159(5):811-821. PubMed ID: 28283868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population.
    Kelleher CL; McFann KK; Johnson AM; Schrier RW
    Am J Hypertens; 2004 Nov; 17(11 Pt 1):1029-34. PubMed ID: 15533729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of OSR-1 With Vascular Dysfunction and Hypertension in Polycystic Kidney Disease.
    Kocyigit I; Taheri S; Eroglu E; Zararsiz G; Sener EF; Uzun I; Imamoglu H; Mehmetbeyoglu E; Unal A; Korkmaz K; Sipahioglu MH; Oymak O; Tokgoz B
    Ther Apher Dial; 2020 Feb; 24(1):64-71. PubMed ID: 31020807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central blood pressure and measures of early vascular disease in children with ADPKD.
    Marlais M; Rajalingam S; Gu H; Savis A; Sinha MD; Winyard PJ
    Pediatr Nephrol; 2019 Oct; 34(10):1791-1797. PubMed ID: 31243534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical presentation and outcome of autosomal dominant polycystic kidney disease in Pakistan: a single center experience.
    Rabbani MA; Ali SS; Murtaza G; Ahmad B; Maria Q; Siddiqui BK; Shah SM; Ahmad A
    J Pak Med Assoc; 2008 Jun; 58(6):305-9. PubMed ID: 18988388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors relating to urinary protein excretion in children with autosomal dominant polycystic kidney disease.
    Sharp C; Johnson A; Gabow P
    J Am Soc Nephrol; 1998 Oct; 9(10):1908-14. PubMed ID: 9773792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis.
    Raina R; Lou L; Berger B; Vogt B; Do AS; Cunningham R; Vasavada P; Herrmann K; Dell K; Simonson M
    BMC Nephrol; 2016 Feb; 17():22. PubMed ID: 26923419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood pressure and intracranial aneurysms in autosomal dominant polycystic kidney disease.
    Niemczyk M; Pilecki T; Gradzik M; Bujko M; Niemczyk S; Pączek L
    Kidney Blood Press Res; 2014; 39(6):630-5. PubMed ID: 25571876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increasing prevalence of hypertension during long-term follow-up in children with autosomal dominant polycystic kidney disease.
    Seeman T; Jansky P; Filip F; Bláhová K; Jaroš A
    Pediatr Nephrol; 2021 Nov; 36(11):3717-3723. PubMed ID: 34008126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Two cases of autosomal dominant polycystic kidney diseases who presented bilateral enlarged kidneys and severe hypertension in the neonatal period].
    Wakaki H; Ikeda M; Hataya H; Ishikura K; Nakashima T; Oosako Y; Honda M
    Nihon Jinzo Gakkai Shi; 2004 Oct; 46(7):719-23. PubMed ID: 15570901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal vascular resistance and renin-angiotensin system in the pathogenesis of early hypertension in autosomal dominant polycystic kidney disease.
    Ramunni A; Saracino A; Esposito T; Saliani MT; Coratelli P
    Hypertens Res; 2004 Apr; 27(4):221-5. PubMed ID: 15127878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine.
    Gronwald W; Klein MS; Zeltner R; Schulze BD; Reinhold SW; Deutschmann M; Immervoll AK; Böger CA; Banas B; Eckardt KU; Oefner PJ
    Kidney Int; 2011 Jun; 79(11):1244-53. PubMed ID: 21389975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tubular secretion of creatinine in autosomal dominant polycystic kidney disease: consequences for cross-sectional and longitudinal performance of kidney function estimating equations.
    Spithoven EM; Meijer E; Boertien WE; Sinkeler SJ; Tent H; de Jong PE; Navis G; Gansevoort RT
    Am J Kidney Dis; 2013 Sep; 62(3):531-40. PubMed ID: 23714171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.